Cargando…

Evaluating smoking cessation interventions in China’s primary care facility networks for hypertensive patients aged 45 years and older: A retrospective cohort study

INTRODUCTION: In China’s aging population, hypertension, aggravated by smoking, constitutes a substantial health concern. However, the effectiveness of the national public health interventions for smoking cessation under the Essential Public Health Services remains unverified. Our aim was to examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Salamanca, Ludwing F., Sanchez, Carmen S., Fang, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523951/
https://www.ncbi.nlm.nih.gov/pubmed/37772271
http://dx.doi.org/10.18332/tid/169975
_version_ 1785110650430685184
author Wang, Yang
Salamanca, Ludwing F.
Sanchez, Carmen S.
Fang, Hai
author_facet Wang, Yang
Salamanca, Ludwing F.
Sanchez, Carmen S.
Fang, Hai
author_sort Wang, Yang
collection PubMed
description INTRODUCTION: In China’s aging population, hypertension, aggravated by smoking, constitutes a substantial health concern. However, the effectiveness of the national public health interventions for smoking cessation under the Essential Public Health Services remains unverified. Our aim was to examine smoking prevalence, the proportion of individuals receiving smoking cessation advice, its impact on successful cessation among Chinese hypertensive patients aged ≥45 years, and to discern disparities in the coverage and efficacy of smoking cessation interventions between primary care facilities and hospitals. METHODS: Employing a longitudinal cohort approach, we examined four waves (2011–2018) of the China Health and Retirement Longitudinal Study (CHARLS). We surveyed a nationally representative cohort of hypertensive individuals, accounting for smoking status, cessation advice, healthcare preferences, and 11 pertinent covariates. RESULTS: Among the 4269 hypertensive patients, smokers were predominantly male, aged <65 years, with lower education and lower wealth. Smoking prevalence decreased from 25.2% in 2011 to 21.1% in 2018. The incidence of physician-provided smoking cessation advice reached a peak of 60.3% in 2015, decreasing to 54.8% in 2018. Visitors to primary care facilities reported the highest rate of advice reception. While patients receiving advice exhibited a higher smoking prevalence, instrumental variable regression and subgroup analyses found no significant correlation between advice receipt and successful cessation. CONCLUSIONS: We observed a substantial smoking prevalence among older hypertensive Chinese individuals and limited effectiveness of existing cessation programs. This underscores the necessity for augmenting primary care and devising a comprehensive health policy for more successful smoking cessation interventions, particularly considering China’s rapidly aging population.
format Online
Article
Text
id pubmed-10523951
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID)
record_format MEDLINE/PubMed
spelling pubmed-105239512023-09-28 Evaluating smoking cessation interventions in China’s primary care facility networks for hypertensive patients aged 45 years and older: A retrospective cohort study Wang, Yang Salamanca, Ludwing F. Sanchez, Carmen S. Fang, Hai Tob Induc Dis Research Paper INTRODUCTION: In China’s aging population, hypertension, aggravated by smoking, constitutes a substantial health concern. However, the effectiveness of the national public health interventions for smoking cessation under the Essential Public Health Services remains unverified. Our aim was to examine smoking prevalence, the proportion of individuals receiving smoking cessation advice, its impact on successful cessation among Chinese hypertensive patients aged ≥45 years, and to discern disparities in the coverage and efficacy of smoking cessation interventions between primary care facilities and hospitals. METHODS: Employing a longitudinal cohort approach, we examined four waves (2011–2018) of the China Health and Retirement Longitudinal Study (CHARLS). We surveyed a nationally representative cohort of hypertensive individuals, accounting for smoking status, cessation advice, healthcare preferences, and 11 pertinent covariates. RESULTS: Among the 4269 hypertensive patients, smokers were predominantly male, aged <65 years, with lower education and lower wealth. Smoking prevalence decreased from 25.2% in 2011 to 21.1% in 2018. The incidence of physician-provided smoking cessation advice reached a peak of 60.3% in 2015, decreasing to 54.8% in 2018. Visitors to primary care facilities reported the highest rate of advice reception. While patients receiving advice exhibited a higher smoking prevalence, instrumental variable regression and subgroup analyses found no significant correlation between advice receipt and successful cessation. CONCLUSIONS: We observed a substantial smoking prevalence among older hypertensive Chinese individuals and limited effectiveness of existing cessation programs. This underscores the necessity for augmenting primary care and devising a comprehensive health policy for more successful smoking cessation interventions, particularly considering China’s rapidly aging population. European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 2023-09-27 /pmc/articles/PMC10523951/ /pubmed/37772271 http://dx.doi.org/10.18332/tid/169975 Text en © 2023 Wang Y. et al. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License.
spellingShingle Research Paper
Wang, Yang
Salamanca, Ludwing F.
Sanchez, Carmen S.
Fang, Hai
Evaluating smoking cessation interventions in China’s primary care facility networks for hypertensive patients aged 45 years and older: A retrospective cohort study
title Evaluating smoking cessation interventions in China’s primary care facility networks for hypertensive patients aged 45 years and older: A retrospective cohort study
title_full Evaluating smoking cessation interventions in China’s primary care facility networks for hypertensive patients aged 45 years and older: A retrospective cohort study
title_fullStr Evaluating smoking cessation interventions in China’s primary care facility networks for hypertensive patients aged 45 years and older: A retrospective cohort study
title_full_unstemmed Evaluating smoking cessation interventions in China’s primary care facility networks for hypertensive patients aged 45 years and older: A retrospective cohort study
title_short Evaluating smoking cessation interventions in China’s primary care facility networks for hypertensive patients aged 45 years and older: A retrospective cohort study
title_sort evaluating smoking cessation interventions in china’s primary care facility networks for hypertensive patients aged 45 years and older: a retrospective cohort study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523951/
https://www.ncbi.nlm.nih.gov/pubmed/37772271
http://dx.doi.org/10.18332/tid/169975
work_keys_str_mv AT wangyang evaluatingsmokingcessationinterventionsinchinasprimarycarefacilitynetworksforhypertensivepatientsaged45yearsandolderaretrospectivecohortstudy
AT salamancaludwingf evaluatingsmokingcessationinterventionsinchinasprimarycarefacilitynetworksforhypertensivepatientsaged45yearsandolderaretrospectivecohortstudy
AT sanchezcarmens evaluatingsmokingcessationinterventionsinchinasprimarycarefacilitynetworksforhypertensivepatientsaged45yearsandolderaretrospectivecohortstudy
AT fanghai evaluatingsmokingcessationinterventionsinchinasprimarycarefacilitynetworksforhypertensivepatientsaged45yearsandolderaretrospectivecohortstudy